Amgen Inc.

NASDAQ: AMGN · Real-Time Price · USD
295.51
5.22 (1.80%)
At close: Aug 15, 2025, 12:46 PM

Amgen Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
11.97B 10.94B 7.63B 7.99B
Short-Term Investments
n/a n/a 1.68B 48M
Long-Term Investments
n/a n/a 3.5B 4.51B
Other Long-Term Assets
9.93B 8.96B 5.9B 6.52B
Receivables
7.5B 7.94B 5.56B 4.89B
Inventory
7B 9.52B 4.93B 4.09B
Other Current Assets
419M 281M 1.18B 1.14B
Total Current Assets
29.03B 30.33B 22.19B 19.39B
Property-Plant & Equipment
6.54B 6.59B 5.43B 5.18B
Goodwill & Intangibles
46.34B 51.27B 31.61B 30.07B
Total Long-Term Assets
62.81B 66.82B 42.94B 41.78B
Total Assets
91.84B 97.15B 65.12B 61.16B
Account Payables
1.91B 1.59B 1.57B 1.37B
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
3.55B 1.44B 1.59B 87M
Other Current Liabilities
1.33B 1.32B 2.33B 2.33B
Total Current Liabilities
23.1B 18.39B 15.69B 12.18B
Long-Term Debt
56.55B 63.17B 37.35B 33.22B
Other Long-Term Liabilities
4.7B 7.01B 8.41B 8.53B
Total Long-Term Liabilities
62.86B 72.53B 45.77B 42.28B
Total Liabilities
85.96B 90.92B 61.46B 54.47B
Total Debt
60.1B 64.61B 38.95B 33.98B
Common Stock
33.53B 33.07B 32.51B 32.1B
Retained Earnings
-27.59B -26.55B -28.62B -24.6B
Comprehensive Income
-66M -289M -231M -796M
Shareholders Equity
5.88B 6.23B 3.66B 6.7B
Total Investments
n/a n/a 5.18B 4.56B